CN Patent
CN109010255B — 阿片样物质制剂
Assigned to Camurus AB · Expires 2022-10-21 · 4y expired
What this patent protects
本发明公开了一种贮库前体制剂,包括:a)控释基质;b)至少含氧有机溶剂;c)至少12重量%的选自丁丙诺啡和其盐的至少一种活性剂,作为丁丙诺啡游离碱计算。提供了相应的贮库组合物和通过阿片样物质维持和相关的方法在疼痛管理中的治疗方法。
USPTO Abstract
本发明公开了一种贮库前体制剂,包括:a)控释基质;b)至少含氧有机溶剂;c)至少12重量%的选自丁丙诺啡和其盐的至少一种活性剂,作为丁丙诺啡游离碱计算。提供了相应的贮库组合物和通过阿片样物质维持和相关的方法在疼痛管理中的治疗方法。
Drugs covered by this patent
- Subutex (BUPRENORPHINE) · Purdue Pharma Lp
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.